When all other treatments failed to cure the two infants of leukemia, doctors at London’s Great Ormond Street Hospital used genetically engineered immune cells from a donor to treat them. Reportedly the children are now in remission. Albeit a medical first, some researchers note that because the children received chemotherapy prior to the experimental treatment, "they failed to show the cell treatment actually cured the kids."
“The patient could be treated immediately, as opposed to taking cells from a patient and manufacturing them,” says Julianne Smith, vice president of CAR-T development for Cellectis, which specializes in supplying universal cells.
In the off-the-shelf approach, blood is collected from a donor and then turned into “hundreds” of doses that can then be stored frozen, says Smith. “We estimate the cost to manufacture a dose would be about $4,000,” she says. That’s compared to a cost of around $50,000 to alter a patient’s cells and return them.
|FDA Approves Bionic Eyes for Implant|
|The Agony of Feeling No Pain|
|"Outrageous things that used to be science fiction are suddenly becoming reality."|
|Cell Transplant Allows Paralysed Man to Walk Again|
|Drinking Soda Pop May Age You Faster|
|How to Avoid Jury Duty|
|“The world’s first hydrogen-powered train.”|
|The Growth of Corruption Reporting Websites|
|The Pirate Supply Store|
|“A dystopian vision of the future is already happening in China.”|
|Japanese Robot Serves Ice Cream From Inside a Vending Machine|
|“Google isn’t liable because it is nothing and nowhere and endless.”|
|“The first-ever driverless mass transit test program.”|
|The (Very Scary) People of Public Transit|
|“When Life Gives You Lemons.”|
|CaptchaTweet: Write Tweets in Captcha Form|
|Why, Typewriters Are Alive and Well, Thank you|